Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 1;75(6):580-588.
doi: 10.1176/appi.ps.20230159. Epub 2024 Feb 13.

An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study

Affiliations

An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study

Jonathan M Wai et al. Psychiatr Serv. .

Abstract

The HEALing (Helping to End Addiction Long-term) Communities Study (HCS) aims to test the effectiveness of the Communities That HEAL intervention in decreasing opioid overdose deaths in 67 communities across four U.S. states. This intervention enlists a collaborative team of researchers, academic experts, and community coalitions to select and implement interventions from a menu of evidence-based practices, including medications for opioid use disorder (MOUD). The HCS's New York team developed an integrated network systems (INS) approach with a mapping tool to coach coalitions in the selection of strategies to enhance medication treatment. With the INS approach, community coalitions develop a map of service delivery venues in their local county to better engage people with medication treatment wherever this need arises. The map is structured around core services that can provide maintenance MOUD and satellite services, which include all settings where people with opioid use disorder are encountered and can be identified, possibly given medication, and referred to core programs for ongoing MOUD care. This article describes the rationale for the INS mapping tool, with a discussion framed by the consolidated framework for implementation research, and provides a case example of its application.

Keywords: Implementation science; Medication-assisted treatment; Medications for opioid use disorder; Opioid use disorder; Overdoses; Public health.

PubMed Disclaimer

Conflict of interest statement

Dr. Blevins has served as a consultant to Pear Therapeutics. Dr. Levin receives grant support from US WorldMeds, research support from Aelis Farma, medication from Indivior for research, and royalties from American Psychiatric Association Publishing. Dr. Levin has served as an advisory board member for Alkermes, Indivior, Novartis, Teva Pharmaceutical Industries, and US WorldMeds and is a consultant to Major League Baseball. Dr. Nunes has received medication or digital therapeutics for research from Alkermes, Braeburn, Indivior, Pear Therapeutics, and CHESS Health and has served as a consultant to Alkermes, Indivior, Pear Therapeutics, and Camurus. The other authors report no financial relationships with commercial interests.

Figures

Figure 1 -
Figure 1 -
Core services/facilities can provide long term medication treatment for opioid use disorder (MOUD), while the connected satellite services/facilities can identify individuals with opioid use disorder and refer to core MOUD providers, or identify, initiate MOUD, and refer to core providers for ongoing MOUD. Arrows represent the movement of individuals between these agencies. DOH: Department of Health; OTP: Opioid Treatment Program.
Figure 2 -
Figure 2 -
Services in dark grey had implementation plan agreements in place while services in light grey did not. Abbreviations: DOH: Department of Health; OTP: Opioid Treatment Program.

Similar articles

References

    1. Wakeman SE, Larochelle MR, Ameli O, et al.: Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder. JAMA Netw Open 2020; 3:e1920622–e1920622 - PMC - PubMed
    1. Mattick RP, Breen C, Kimber J, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014. Feb 6;(2):CD002207 - PMC - PubMed
    1. Weiss RD, Potter JS, Fiellin DA, et al.: Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial. Arch Gen Psychiatry 2011; 68:1238–1246 - PMC - PubMed
    1. Hser Y-I, Evans E, Huang D, et al.: Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial. Addiction 2016; 111: 695–705 - PMC - PubMed
    1. Lee JD, Friedmann PD, Kinlock TW, et al.: Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. N Engl J Med 2016; 374:1232–1242 - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources